30 publications.
Estimation of the Harvey Bradshaw Index from the Patient-Reported Outcome 2 in Crohn’s Disease: Results Based on a Large Scale Randomized Controlled Trial
Khanna R, Son S, Zou G, Roshanov PS
Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis
Roshanov PS, Khanna R
PROACTIVE FECAL CALPROTECTIN MONITORING TO IMPROVE PATIENT OUTCOMES IN ULCERATIVE COLITIS: A PROSPECTIVE RANDOMIZED CONTROL TRIAL (PROMOTE UC)
Rosenfeld G, Narula N, Leung Y, Afif W, Williams A-J, Huang V, Singh H, Mccurdy J, Jairath V, Lam M
The Clinical Interpretation of Cluster Trials
Roshanov PS, Zou G, Khanna R
DOP004 Proactive fecal calprotectin testing in ulcerative colitis: Initial results of the PROMOTE UC study
Rosenfeld G, Narula N, Leung Y, Afif W, Williams AJ, Huang V, Singh H, McCurdy J, Jairath V, Lam M
A Head-to-Head Comparison of Risankizumab and Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn’s Disease
Roshanov PS, Khanna R
The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease
Roshanov PS, Khanna R
The Clinical Interpretation of Noninferiority Trials
Roshanov PS, Khanna R
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
Quan J, Ma C, Panaccione R, Hracs L, Sharifi N, Herauf M, Makovinović A, Coward S, Windsor JW, Caplan L
Continuation of Tumor Necrosis Factor Antagonists for Inflammatory Bowel Diseases During Pregnancy
Roshanov PS, Khanna R
Frequent collaborators
14John Kenneth Marshall
Medicine
11 shared papers, latest 2023
Paul Moayyedi
Medicine
8 shared papers, latest 2019
Grigorios Leontiadis
Medicine
6 shared papers, latest 2019
Neeraj Narula
Medicine
4 shared papers, latest 2025
Yuhong Yuan
Medicine
3 shared papers, latest 2019
Premysl Bercik
Medicine
2 shared papers, latest 2014
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.